WallStreetZenWallStreetZen

NASDAQ: SNSE
Sensei Biotherapeutics Inc Stock Ownership - Who owns Sensei Biotherapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Sensei Biotherapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
John CelebiPRESIDENT AND CEO2025-02-195,558$0.48
$2.65kSell
Der Horst Edward VanCHIEF SCIENTIFIC OFFICER2025-02-192,276$0.48
$1.08kSell

1 of 1

SNSE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SNSE insiders and whales buy or sell their stock.

SNSE Shareholders

What type of owners hold Sensei Biotherapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
James Peyer701.48%8,841,457$78.25MInsider
Hs Investments I LP351.16%4,425,998$39.17MInsider
Cambrian Biopharma Inc289.84%3,653,120$32.33MInsider
Thomas G. Ricks54.40%685,632$6.07MInsider
Vanguard Group Inc46.46%585,576$5.18MInstitution
Ikarian Capital LLC35.70%449,963$3.98MInstitution
Catalio Capital Management LP23.36%294,374$2.61MInstitution
Renaissance Technologies LLC14.07%177,300$1.57MInstitution
Geode Capital Management LLC11.96%150,709$1.33MInstitution
Boothbay Fund Management LLC8.62%108,658$961.62kInstitution

1 of 3

SNSE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SNSE9.58%90.42%Net Selling
BTAI0.19%99.81%Net Selling
IMNN2.34%63.55%Net Buying
KAPA9.36%40.23%Net Buying
ABP2.59%53.89%Net BuyingNet Buying
View Top Biotech Stocks

Sensei Biotherapeutics Stock Ownership FAQ

Who owns Sensei Biotherapeutics?

Sensei Biotherapeutics (NASDAQ: SNSE) is owned by 151.77% institutional shareholders, 1,432.29% Sensei Biotherapeutics insiders, and 0.00% retail investors. James Peyer is the largest individual Sensei Biotherapeutics shareholder, owning 8.84M shares representing 701.48% of the company. James Peyer's Sensei Biotherapeutics shares are currently valued at $81.92M.

If you're new to stock investing, here's how to buy Sensei Biotherapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.